Navigation Links
Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
Date:5/29/2012

overall survival benefit," said Denise A. Yardley, MD, breast program leader, senior investigator at the Sarah Cannon Research Institute and principal investigator of the study. "Moreover, the addition of entinostat to exemestane translated into an increase in progression-free survival of over six months in the subset of patients treated with this novel combination that demonstrated protein lysine hyperacetylation.  This suggests that evaluating evidence of protein hyperacetylation may be an exciting opportunity to explore whether we could use this biomarker to identify patients most likely to benefit from the addition of entinostat to standard hormone therapy.  These results continue to support the promise of entinostat for women with advanced breast cancer and I am eager to move forward with the confirmatory phase 3 study."

ENCORE 301 (ENtinostat Combinations Overcoming REsistance) was a multicenter, randomized, double-blind, placebo-controlled, phase 2 study of exemestane with and without entinostat in 130 post-menopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer, progressing on treatment with the non-steroidal aromatase inhibitors anastrozole or letrozole.  The study hit the primary endpoint of progression-free survival and preliminary analysis indicated an overall survival benefit. Entinostat was well tolerated with fatigue, nausea and uncomplicated neutropenia as the most commonly occurring adverse events. Pharmacodynamic analysis in a subset of patients linked for the first time a readout of histone deacetylase inhibitor activity with clinical outcome.

The abstract titled, "Characterization of the overall survival benefit in ENCORE 301, a randomized placebo-controlled phase 2 study of exemestane with and without entinostat in ER+ post-menopausal women with metastatic breast cancer" highlighted the following results:

  • Analysis of OS across m
    '/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Syndax Pharmaceuticals Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
5. Syndax Pharmaceuticals Entinostat in Combination Shows Activity in Breast Cancer
6. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
7. Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
8. Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
9. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
10. Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat
11. Syndax Pharmaceuticals Elects Arlene Morris to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Orthopedic Soft ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About Orthopedic ... the mass of cells that connect, support, or ... soft tissues such as tendons, ligaments, cartilage, fascia, ...
(Date:8/27/2014)... 2014 Decision Resources Group finds that the ... Memphis health system and hospital sector in ... rivals Methodist Le Bonheur Healthcare and Baptist Memorial Health ... patient care. In addition, a national contract recently signed ... plan enrollment in the Memphis ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Heart ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart ... in the human heart which control the flow ... affected with heart valve diseases such as valvular ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Memphis-area Health Systems Turn Attention to Clinical Integration 2Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
(Date:8/28/2014)... Tea Leaves Health is pleased to ... in Connected Consumer Management. By integrating Gigya’s innovative ... opportunity to build more authentic relationships with its ... how they like to interact. , Gigya’s Connected ... to understand and connect with mobile and socially ...
(Date:8/28/2014)... Asheville, NC (PRWEB) August 28, 2014 ... October 24-26, 2014 in Asheville, NC at holistic ... by ChiRunning & ChiWalking founders, Katherine and Danny ... the ability to learn techniques that support a ... serene setting. , Nestled in the heart ...
(Date:8/28/2014)... Alpine, NJ resident Othon Mourkakos is ... Zebras In Tiaras, to benefit the Immune Deficiency Foundation ... 26, 2014 in Foley Square, New York. IDF ... immunodeficiency diseases (PI) are a group of more than ... the body’s immune system is missing or functions improperly. ...
(Date:8/28/2014)... 2014 MMAR Medical is pleased to ... chance for regular customers to enjoy several perks and ... for a wholesale license. It’s a great choice for ... and others who regularly purchase medical braces but could ... your own active lifestyle or those of your club, ...
(Date:8/28/2014)... 2014 Coveros, Inc., the market ... it has partnered with InfoZen on the contract ... date of 2/4/2014 with U.S. Citizenship and Immigration ... agency that oversees lawful immigration to the United ... will automate the integration and delivery of critical ...
Breaking Medicine News(10 mins):Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Join ChiRunning® & ChiWalking® Creators, Katherine and Danny Dreyer, for First-ever ChiWeekend Retreat in Asheville, NC 2Health News:Join ChiRunning® & ChiWalking® Creators, Katherine and Danny Dreyer, for First-ever ChiWeekend Retreat in Asheville, NC 3Health News:MMAR Medical Announces Customer Membership Program 2Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2
... stay healthy, , , TUEDAY, Sept. 25 (HealthDay News) -- Lifestyles ... too much junk food are pushing U.S. children toward a ... finds. , The studies -- published in a special supplement ... show the myriad challenges youngsters face every day in trying ...
... the American Cancer Society finds the breast cancer death rate in ... year, a trend that began in 1990 and is credited to ... American women and women of other racial and ethnic groups have ... to those gains, and that a recent drop in cancer incidence ...
... Provides Cost-Effective, Highly Available and Secure Data, Replication ... Retirement Funds, EDEN PRAIRIE, Minn., Sept. 25 ... Workers of America (UMWA) Health and,Retirement Funds has ... its new data disaster recovery plan. The,hosted service ...
... Provides State-By-State Comprehensive Planning Resources ... ... than 16 million baby,boomers currently supporting or caring for both a ... faced,with the issue of finding adequate resources to support loved ones.,Care.com(SM) ...
... Va., Sept. 25 The American Society,for Therapeutic ... of,its brochure Radiation Therapy for Gynecologic Cancers. The ... information on the,different types of radiation therapy and ... the potential side effects and how to care ...
... Spaniards have very poor knowledge about cancer, its causes, treatment ... in and around Barcelona. Some even believe that cancer is ... something bad that the patient has done. , In ... (ECCO 14) in Barcelona, Dr Tania Estap said: This reports ...
Cached Medicine News:Health News:Junk Food, TV Driving Kids to Obesity 2Health News:Junk Food, TV Driving Kids to Obesity 3Health News:Junk Food, TV Driving Kids to Obesity 4Health News:American Cancer Society report finds breast cancer death rate continues to drop 2Health News:American Cancer Society report finds breast cancer death rate continues to drop 3Health News:American Cancer Society report finds breast cancer death rate continues to drop 4Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 2Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 3Health News:Care.com Launches Senior Care Directory 2Health News:Care.com Launches Senior Care Directory 3Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2Health News:Survey reveals ignorance and confusion about cancer amongst the elderly 2Health News:Survey reveals ignorance and confusion about cancer amongst the elderly 3
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
Medicine Products: